{"id":5515,"date":"2022-07-21T00:00:00","date_gmt":"2022-10-14T16:15:37","guid":{"rendered":"https:\/\/mdbc1.wpengine.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/"},"modified":"2023-06-13T15:34:05","modified_gmt":"2023-06-13T19:34:05","slug":"prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite","status":"publish","type":"eb_course","link":"http:\/\/www.mdbriefcase.com\/fr\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/","title":{"rendered":"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9"},"content":{"rendered":"<p><span class=\"gmail-normaltextrun\">La pharmacoth\u00e9rapie employ\u00e9e dans le traitement de l\u2019ob\u00e9sit\u00e9 continue d\u2019\u00e9voluer. Quatre m\u00e9dicaments sont aujourd\u2019hui disponibles au Canada pour aider les patients atteints d\u2019ob\u00e9sit\u00e9 \u00e0 atteindre leurs objectifs th\u00e9rapeutiques. Ceux-ci comprennent l\u2019orlistat et trois options plus r\u00e9centes : l\u2019association naltrexone\/bupropion, le liraglutide \u00e0 3,0 mg et le s\u00e9maglutide \u00e0 2,4 mg. Dans cette baladodiffusion, la D<sup>re<\/sup> Nadine Roy et le pharmacien Sylvain Cormier discutent des profils des quatre m\u00e9dicaments utilis\u00e9s au Canada dans le traitement de l\u2019ob\u00e9sit\u00e9, dans le but d\u2019appuyer le choix le plus appropri\u00e9 pour chaque patient, d\u2019encourager une observance optimale et d\u2019offrir des conseils et astuces pour prendre en charge les effets ind\u00e9sirables, particuli\u00e8rement durant les premi\u00e8res semaines de traitement. <\/span>    <\/p>\n<hr>\n<p>Ce programme de formation a fait l\u2019objet d\u2019une bourse \u00e0 vis\u00e9e \u00e9ducative ou d\u2019un soutien en nature de la part de Novo Nordisk. <\/p>","protected":false},"featured_media":450686,"comment_status":"open","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-5515","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"La pharmacoth\u00e9rapie employ\u00e9e dans le traitement de l\u2019ob\u00e9sit\u00e9 continue d\u2019\u00e9voluer. Quatre m\u00e9dicaments sont aujourd\u2019hui disponibles au Canada pour aider les patients atteints d\u2019ob\u00e9sit\u00e9 \u00e0 atteindre leurs objectifs th\u00e9rapeutiques. Ceux-ci comprennent l\u2019orlistat et trois options plus r\u00e9centes : l\u2019association naltrexone\/bupropion, le liraglutide \u00e0 3,0 mg et le s\u00e9maglutide \u00e0 2,4 mg. Dans cette baladodiffusion, la Dre [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-13T19:34:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"338\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/\",\"name\":\"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg\",\"datePublished\":\"2022-10-14T16:15:37+00:00\",\"dateModified\":\"2023-06-13T19:34:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg\",\"width\":600,\"height\":338},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/","og_locale":"fr_CA","og_type":"article","og_title":"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase","og_description":"La pharmacoth\u00e9rapie employ\u00e9e dans le traitement de l\u2019ob\u00e9sit\u00e9 continue d\u2019\u00e9voluer. Quatre m\u00e9dicaments sont aujourd\u2019hui disponibles au Canada pour aider les patients atteints d\u2019ob\u00e9sit\u00e9 \u00e0 atteindre leurs objectifs th\u00e9rapeutiques. Ceux-ci comprennent l\u2019orlistat et trois options plus r\u00e9centes : l\u2019association naltrexone\/bupropion, le liraglutide \u00e0 3,0 mg et le s\u00e9maglutide \u00e0 2,4 mg. Dans cette baladodiffusion, la Dre [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/","og_site_name":"MDBriefCase","article_modified_time":"2023-06-13T19:34:05+00:00","og_image":[{"width":600,"height":338,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/","url":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/","name":"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9 - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg","datePublished":"2022-10-14T16:15:37+00:00","dateModified":"2023-06-13T19:34:05+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2022\/07\/Management-Side-Effects-Drug-Therapy-Obesity-1335204536-600-23.jpg","width":600,"height":338},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/prise-en-charge-des-effets-secondaires-de-la-pharmacotherapie-pour-lobesite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Prise en charge des effets secondaires de la pharmacoth\u00e9rapie pour l\u2019ob\u00e9sit\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=5515"}],"version-history":[{"count":0,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/5515\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/450686"}],"wp:attachment":[{"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=5515"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"http:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=5515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}